Human CD38 (Research Grade Daratumumab Biosimilar) Alexa Fluor® 350-conjugated Antibody
Human CD38 (Research Grade Daratumumab Biosimilar) Alexa Fluor® 350-conjugated Antibody Summary
Met1-Ile300
Accession # P28907
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Reconstitution Calculator
Preparation and Storage
Background: CD38
CD38, also known as ADP-ribosyl cyclase, is a Type II integral membrane protein. The enzyme is able to transform NAD(P)+ into three different products with calcium mobilizing ability, cyclic ADP-ribose, NAADP+, and ADP-ribose (1). CD38 is expressed in B and T lymphocytes, osteoclasts, and in cardiac, pancreatic, liver and kidney cells (2, 3). Through its production of cyclic ADP-ribose, CD38 modulates calcium-mediated signal transduction in many types of cells, including neutrophils and pancreatic beta cells (4, 5). Bio-Techne's Daratumumab biosimilar is produced using the full-length amino acid sequence which is identical to that of the original therapeutic antibody.
Product Datasheets
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human CD38 (Research Grade Daratumumab Biosimilar) Alexa Fluor® 350-conjugated Antibody
There are currently no reviews for this product. Be the first to review Human CD38 (Research Grade Daratumumab Biosimilar) Alexa Fluor® 350-conjugated Antibody and earn rewards!
Have you used Human CD38 (Research Grade Daratumumab Biosimilar) Alexa Fluor® 350-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
